Skip to main content

Publications

What type of publication do you want to show?

2024

HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.

Shafiqa, N., Aston, S., Howard, A., Turtle, L., Abrams, S., Young, B., . . . Wootton, D. G. (2024). HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.. BMJ open, 14(7), e088490. doi:10.1136/bmjopen-2024-088490

DOI
10.1136/bmjopen-2024-088490
Journal article

Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.

Flett, L., Abdelatif, R., Baz, S. A., Brady, S., Corbacho, B., Common, K., . . . Barlow, G. (2024). Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.. Trials, 25(1), 427. doi:10.1186/s13063-024-08272-w

DOI
10.1186/s13063-024-08272-w
Journal article

Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing.

Reza, N., Gerada, A., Stott, K. E., Howard, A., Sharland, M., & Hope, W. (2024). Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing.. Clinical microbiology reviews, 37(2), e0013923. doi:10.1128/cmr.00139-23

DOI
10.1128/cmr.00139-23
Journal article

Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop.

Howard, A., Reza, N., Aston, S., Woods, B., Gerada, A., Buchan, I., . . . Märtson, A. -G. (2024). Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop.. The Lancet. Infectious diseases, 24(1), e47-e58. doi:10.1016/s1473-3099(23)00367-5

DOI
10.1016/s1473-3099(23)00367-5
Journal article

2023

48 Describing the epidemiological characteristics and treatment patterns of non-tuberculosis mycobacteria (NTM) infections in adults in Liverpool 2010–2022

Todd, H., Haigh, K., Frost, F., Green, D., Aston, S., Howard, A., . . . Davies, G. (2023). 48 Describing the epidemiological characteristics and treatment patterns of non-tuberculosis mycobacteria (NTM) infections in adults in Liverpool 2010–2022. Clinical Infection in Practice, 20, 100307. doi:10.1016/j.clinpr.2023.100307

DOI
10.1016/j.clinpr.2023.100307
Journal article

ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

Howard, A., Hope, W., & Gerada, A. (2023). ChatGPT and antimicrobial advice: the end of the consulting infection doctor?. LANCET INFECTIOUS DISEASES, 23(4), 405. doi:10.1016/S1473-3099(23)00113-5

DOI
10.1016/S1473-3099(23)00113-5
Journal article

ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

Howard, A., Hope, W., & Gerada, A. (2023). ChatGPT and antimicrobial advice: the end of the consulting infection doctor?. LANCET INFECTIOUS DISEASES, 23(4), 405-406. Retrieved from https://www.webofscience.com/

Journal article

2022

Piperacillin/tazobactam-resistant, cephalosporin-susceptible <i>Escherichia coli</i> bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types

Edwards, T., Heinz, E., van Aartsen, J., Howard, A., Roberts, P., Corless, C., . . . Hubbard, A. T. M. (2022). Piperacillin/tazobactam-resistant, cephalosporin-susceptible <i>Escherichia coli</i> bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types. MICROBIAL GENOMICS, 8(4). doi:10.1099/mgen.0.000789

DOI
10.1099/mgen.0.000789
Journal article

2020

Piperacillin/tazobactam resistance in a clinical isolate of <i>Escherichia coli</i> due to IS<i>26</i>-mediated amplification of <i>bla</i><sub>TEM-1B</sub>

Hubbard, A. T. M., Mason, J., Roberts, P., Parry, C. M., Corless, C., van Aartsen, J., . . . Edwards, T. (2020). Piperacillin/tazobactam resistance in a clinical isolate of <i>Escherichia coli</i> due to IS<i>26</i>-mediated amplification of <i>bla</i><sub>TEM-1B</sub>. NATURE COMMUNICATIONS, 11(1). doi:10.1038/s41467-020-18668-2

DOI
10.1038/s41467-020-18668-2
Journal article

Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting

Corless, C. E., Howard, A. M., & Neal, T. J. (2020). Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting. INFECTION PREVENTION IN PRACTICE, 2(3). doi:10.1016/j.infpip.2019.100011

DOI
10.1016/j.infpip.2019.100011
Journal article

2015

Diagnosing osteomyelitis in diabetes foot ulceration

Srinivas-Shankar, U., Howard, A. M., Pendlebury, H., Mathews, M., Milligan, K., Ford, N., & Khalathil, D. (2015). Diagnosing osteomyelitis in diabetes foot ulceration. In DIABETIC MEDICINE Vol. 32 (pp. 151). Retrieved from https://www.webofscience.com/

Conference Paper